Related Experiment Video
Updated: Apr 21, 2026

Accessing Valuable Ligand Supports for Transition Metals: A Modified, Intermediate Scale Preparation of 1,2,3,4,5-Pentamethylcyclopentadiene
Published on: March 20, 2017
Tuning the emission lifetime in bis-cyclometalated iridium(III) complexes bearing iminopyrene ligands
Ashlee J Howarth1, David L Davies, Francesco Lelj
1Department of Chemistry, University of British Columbia , Vancouver, British Columbia V6T 1Z1, Canada.
Abstract:
Bis-cyclometalated Ir(III) complexes with the general formula Ir(ppz)2(X^NPyrene), where ppz = 1-phenylpyrazole and X^NPyrene is a bidentate chelate with X = N or O, are reported. Modifications on the ancillary ligand containing pyrene drastically affect the emission lifetimes observed (0.329 to 104 μs). Extended emission lifetimes in these complexes compared to model complexes result from reversible electronic energy transfer or the observation of dual emission containing along-lived pyrene ligand-centered triplet ((3)LC) component. A combination of steady-state and time-resolved spectroscopic techniques are used to observe reversible electronic energy transfer in solution between the iridium core and pyrene moiety in the complex [Ir(ppz)2(NMe^NCH2Pyr)][PF6] (2), where NMe^NCH2Pyr = N-(pyren-1-ylmethyl)-1-(pyridin-2-yl)ethaneimine. Studies on [Ir(ppz)2(NMe^NCH2Pyr)][PF6] in a poly(methyl methacrylate) (PMMA) film reveal that reversible energy transfer is no longer effective, and instead, dual emission with a long-lived (3)LC component from pyrene is observed. Dual emission is observed in additional cyclometalated iridium complexes bearing pyrene-containing ancillary ligands N^NPyrene and O^NPyrene when the complexes are dispersed in a PMMA film.
More Related Videos
07:11ARL Spectral Fitting as an Application to Augment Spectral Data via Franck-Condon Lineshape Analysis and Color Analysis
Published on: August 19, 2021
07:20Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014